1,064 results on '"Sanchez-Salas, Rafael"'
Search Results
2. Development of the European Laparoscopic Intermediate Urological Skills LUSs2 Curriculum: A Delphi Consensus from the European School of Urology
3. The diagnostic accuracy of micro-ultrasound for prostate cancer diagnosis: a review
4. Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study
5. The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations
6. Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium
7. The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study
8. Urinary Symptoms Change and Quality of Life After Robotic Radical Prostatectomy: A Secondary Analysis of a Randomized Controlled Trial
9. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus
10. Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison
11. Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study
12. Ileal Conduit Versus Orthotopic Neobladder Urinary Diversion in Robot-assisted Radical Cystectomy: Results from a Multi-institutional Series
13. Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer
14. Outcomes of ablative therapy and radical treatment for prostate cancer: a systematic review and meta-analysis
15. Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy
16. Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison
17. Salvage local treatment for recurrent prostate cancer after focal therapy: A systematic review and meta-analysis
18. The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging in Primary and Recurrent Prostate Cancer: A Systematic Review of the Literature
19. The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance
20. Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance
21. Radical Cystectomy
22. Salvage Treatment after Focal Therapy for Recurrent Prostate Cancer
23. Letter: Point of View: What Are We Doing? The Incredible Expense and Uncertain Value of Localized Prostate Cancer Diagnostic and Therapeutic “Advances”
24. MP25-10 SALVAGE LOCAL TREATMENT FOR RECURRENT PROSTATE CANCER AFTER FOCAL THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
25. MP68-07 PROPORTION OF GLEASON 8-10 PROSTATE CANCER FOUND ON BIOPSY AND TUMOR AGGRESSIVENESS IN MATCHED COHORTS OF MEN IN ASIA AND WESTERN COUNTRIES
26. MP25-16 FOCAL CRYOTHERAPY FOR LOCALIZED PROSTATE CANCER: INITIAL REPORT FROM THE INTERNATIONAL FOCAL THERAPY SOCIETY (FTS) REGISTRY
27. PD01-07 NATURAL HISTORY OF PN1 PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: COMPETING RISK ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES
28. The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review
29. The FocAL therapy CONsensus (FALCON): enhancing partial gland ablation for localised prostate cancer
30. Humoral complementomics – exploration of noninvasive complement biomarkers as predictors of renal cancer progression
31. Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer
32. Focal Brachytherapy for Localized Prostate Cancer: Midterm Outcomes
33. Accuracy of MRI-guided Versus Systematic Prostate Biopsy in Patients Under Active Surveillance: A Systematic Review and Meta-analysis
34. Development of the European Laparoscopic Intermediate Urological Skills LUSs2 Curriculum: A Delphi Consensus from the European School of Urology
35. The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study
36. The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET):A Systematic Review and International Consensus Recommendations
37. Making a case “for” focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials
38. Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review
39. Erectile Recovery After Radical Pelvic Surgery: Methodological Challenges and Recommendations for Data Reporting
40. Candid choices: optimising patient selection in prostate cancer focal therapy
41. Editorial: Special issue on focal therapy: Updating our knowledge
42. Infectious complications of prostate biopsy: winning battles but not war
43. Visceral and Gastrointestinal Complications in Robotic Urologic Surgery
44. The European Urology Residents Education Programme Hands-on Training Format: 4 Years of Hands-on Training Improvements from the European School of Urology
45. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer
46. Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery
47. Chapter 19 - The formation and the training of robotic surgeons
48. Optimal Surgical Outcome of Minimally Invasive Partial Nephrectomy (MIPN) Based on an Early Postoperative Estimated Glomerular Filtration Rate (eGFR)
49. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel
50. Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.